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RNA interference (RNAi) is a conserved gene-silencing phenomenon that can be triggered by delivery of double-stranded
RNA (dsRNA) to cells and is a widely exploited technology in analyses of gene function. Although a number of proteins
that facilitate RNAi have been identified, current descriptions of RNAi and interrelated mechanisms are far from
complete. Here, we report that the Caenorhabditis elegans gene haf-6 is required for efficient RNAi. HAF-6 is a member
of the ATP-binding cassette (ABC) transporter gene superfamily. ABC transporters use ATP to translocate small molecule
substrates across the membranes in which they reside, often against a steep concentration gradient. Collectively, ABC
transporters are involved in a variety of activities, including protective or barrier mechanisms that export drugs or toxins
from cells, organellar biogenesis, and mechanisms that protect against viral infection. HAF-6 is expressed predominantly
in the intestine and germline and is localized to intracellular reticular organelles. We further demonstrate that eight
additional ABC genes from diverse subfamilies are each required for efficient RNAi in C. elegans. Thus, the ability to
mount a robust RNAi response to dsRNA depends upon the deployment of two ancient systems that respond to
environmental assaults: RNAi mechanisms and membrane transport systems that use ABC proteins.
INTRODUCTION
When introduced into eukaryotic cells, double-stranded
RNA (dsRNA) elicits a foreign genome response that is
orchestrated by RNA interference (RNAi) mechanisms (Fire
et al., 1998). RNAi results in the directed decay of mRNAs
with sequences related to the input dsRNA (Montgomery et
al., 1998), and in some cases, transcriptional-level silencing
of genes with similar sequence (Bernstein and Allis, 2005;
Grishok, 2005). RNAi mechanisms are conserved in eu-
karyotes and protect organisms from potentially deleterious
nucleic acids such as those found in transposons and viruses
(Robert et al., 2004; Vastenhouw and Plasterk, 2004; Li and
Ding, 2005). Many of the components of the RNAi mecha-
nism are shared with related RNA-directed silencing path-
ways, and the collective silencing mechanisms have vital
functions in cells and in development. For example, RNAi
and related pathways participate in the establishment and
proper functioning of heterochromatin, in regulation of gene
expression, and in posttranscriptional regulation of cellular
mRNAs by microRNAs (miRNAs) and endogenous small
interfering RNAs (siRNAs) (Grewal and Rice, 2004; Noma et
al., 2004; Du and Zamore, 2005; Lee et al., 2006). Some of the
different pathways use common proteins that may be limit-
ing in availability, and emerging evidence suggests compe-
tition between RNA-directed silencing mechanisms under
certain conditions (Duchaine et al., 2006; Lee et al., 2006). The
interrelatedness of RNAi mechanisms and the number of
RNAi components with essential roles in development ne-
cessitate a better and broader understanding of RNAi mech-
anisms and pathways.
A number of conserved proteins that effect gene silencing
in response to dsRNA have been uncovered through analy-
ses of Caenorhabditis elegans mutants that are defective in
RNAi. Altogether, the genes function in the processing of
exogenous dsRNA into siRNAs; in processing of endoge-
nous precursor RNAs into siRNAs, miRNAs, and tiny non-
coding RNAs; in RNA-dependent RNA polymerase-de-
pendent activities associated with RNAi responses; in
inhibition of RNAi; in cellular mechanisms that allow pas-
sive entry of small dsRNA molecules into cells; in mecha-
nisms that presumably use endocytosis machinery to al-
low cellular entry of dsRNAs; and in mechanisms that
modify chromatin (Ketting et al., 1999; Tabara et al., 1999;
Smardon et al., 2000; Knight and Bass, 2001; Sijen et al.,
2001; Dudley et al., 2002; Simmer et al., 2002; Tabara et al.,
2002; Tijsterman et al., 2002a,b, 2004; Winston et al., 2002;
Caudy et al., 2003; Timmons et al., 2003; Kennedy et al.,
2004; Grishok et al., 2005; Kim et al., 2005; Tops et al., 2005;
Wang et al., 2005). Although a number of genes that
function in RNAi have been identified using C. elegans, the
list is far from complete.
C. elegans remains an important genetics tool for the elu-
cidation of RNAi mechanisms in multicellular animals. Ge-
netic screening is facilitated by a number of protocols that
are available for dsRNA delivery. dsRNA can be introduced
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to C. elegans via feeding (allowing animals to ingest bacteria
engineered to express dsRNA) (Timmons et al., 2001), by
soaking animals in solutions containing dsRNA (Tabara et
al., 1998), and by injecting animals with dsRNA (Fire, 1999),
and all methods can elicit a systemic RNAi response in treated
animals and their progeny. dsRNA delivered to animals using
bacterial “food” is introduced at a relatively lower dosage,
allowing for the identification of mutants with subtle or tissue-
specific RNAi defects, or allowing for the identification of
hypomorphic mutations in otherwise essential genes.
Here, we demonstrate that the Caenorhabditis elegans ATP-
binding cassette (ABC) transporter gene haf-6 is required for
efficient RNAi and that eight additional ABC transporters
have similar roles in RNAi.
MATERIALS AND METHODS
C. elegans Strains
Worm husbandry and genetic crosses were performed according to standard
protocols (Brenner, 1974). The following strains, used in mapping, were generous
gifts from Dr. Andrew Fire (Stanford University, Stanford, MA): LGI: dpy-5(e61)
unc-54(e1092); LGIV: unc-17(e245) dpy-4(e1166); LGV: dpy-11(e224) unc-60(e723);
LGII: dpy-10(e128) unc-52(e669); and LGIII: dpy-18(e449) unc-32(e189).
The haf-6(ne335) strain was a generous gift from Craig Mello (University of
Massachusetts Medical School, Worcester, MA) (Tabara et al., 1999). The
following mutants were used in phenotypic analyses and were obtained from
the C. elegans Genetics Center (University of Minnesota, Minneapolis, MN) or
the National Bioresources Project in Japan: abt-1(tm703); abt-2(ok669); abt-
4(ok633); C05D10.3(tm688); C56E6.1(ok865); cft-1(ok1180); C16C10.12(2 alleles:
ok927, ok962); ced-7(5 alleles: n2690, n1892, n2094, n1996, n1997); F02E11.1(ok1007);
F19B6.4(ok806); haf-1(ok705); haf-2(gk13); haf-3(ok1086); haf-4(2 alleles: gk240,
ok1042); haf-5(2 alleles: gk155, gk161); haf-7(gk46); haf-8(gk12); haf-9(gk23); mrp-
1(pk89); mrp-3(ok955); mrp-4(ok1095); mrp-6(ok1027); mrp-8(ok1360); NL130:
pgp-1(pk17), pgp-3(pk18); NL132: pgp-1(pk17); NL152: pgp-1(pk17), pgp-3(pk18),
mrp-1(pk89); pgp-10(ok991); pgp-11(tm333); pgp-12(gk19); pgp-13(ok747); pgp-
15(ok987); pgp-2(gk114); NL131: pgp-3(pk18); pgp-4(gk16); pgp-5(ok856); pgp-
7(ok528); pmp-1(ok773); pmp-3(ok1087); pmp-4(ok396); RB1047: deletion in pgp-6 and
pgp-7(ok994); T26A5.1(ok882); T27E9.7(ok771); F18E2.2(ok830); Y42g9a.6(ok812);
and Y49e10.9(ok1044).
Feeding Strains and Feeding-based Assays for RNAi Defects
“Feeding plates” harboring bacteria engineered to express dsRNA were pre-
pared using HT115(DE3) host bacteria as described previously (Timmons et
al., 2001; Hull and Timmons, 2004). Plasmid L4440 was the cloning vector for
plasmids transformed into this bacterial strain (Timmons and Fire, 1998).
HT115(DE3) strains harboring a pop-1 cDNA insert in L4440 (pop-1 food)
targets the TCF/LEF1 transcription factor and produces sterility in young
animals reared on this food. unc-22 food (Timmons and Fire, 1998) targets the
muscle-specific unc-22 transcript and induces a twitching phenotype. Other
feeding strains were obtained from MRC/Geneservice RNAi library (Kamath
et al., 2003), or they were generated by inserting PCR-generated fragments of
cDNAs into L4440.
RNAi was induced using the feeding protocol by placing animals as L1/L2
larvae onto fresh plates prepared as described previously (Timmons et al.,
2001; Hull and Timmons, 2004). In each experiment, control feeding plates
with wild-type worms and OP50 plates with mutant worms were used to
monitor for effectiveness of the delivery protocol and for potential environ-
mental contributions to the phenocopy, respectively. Assays were performed
at 15, 20, and 25°C. pop-1(RNAi) was assayed by tabulating the number of
viable progeny produced per adult on the feeding plate. This value can be
affected by temperature, the time frame of the experiment, and the staging of
the animals at the time of placement onto the feeding plate; therefore, the
value is comparative, not absolute. In each experiment, RNAi phenocopies in
mutants were closely compared with similarly treated wild-type worms.
Comparative values for unc-22(RNAi) activity were obtained by calculating
the percentage of F1 animals that twitch.
Positional Cloning of haf-6(ne335), Transgene Rescue of
RNAi Defects, and Complementation Tests with smg-2
Ingestion of pos-1 food by wild-type adults can induce lethality in resulting
embryos—the presence of viable progeny is evidence of an RNAi defect.
haf-6(ne335) mutants were isolated in a screen for RNAi-defective animals
using pos-1 food (Tabara et al., 1999). haf-6(ne335) is recessive, and ne335 is the
only haf-6 allele to date. Many RNAi-defective strains have no other pheno-
types, and this raises the potential that a second uncharacterized mutation
might contribute to RNAi defects in some strains. To assay for, or guard
against, this possibility, we produced different versions of haf-6(ne335) strains
by outcrossing ne335 to various wild-type stocks from different origins (e.g.,
N2 stocks obtained from the C. elegans Genetics Center versus N2 stocks
maintained for several years in the laboratory of Andrew Fire). We selected
for robust RNAi activity, viability, and fertility at 25°C, and for normal brood
sizes in wild-type animals before using them in outcrosses. In initial stages of
mutant characterization, feeding assays were used to select for ne335 homozy-
gotes; later, a PCR strategy was used to identify mutant homozygotes from
additional outcrosses. Primers 683 GCCATCCTCTCAGCCTAC and 684
CCACCCACGCTCTTACATG were used in genotyping. The differently out-
crossed ne335 strains behaved identically in our assays.
A rough genetic map was obtained using two- and three-factor mapping
strategies and genetically marked strains. Heterozygous F1 cross-progeny
were set aside and allowed to produce F2 progeny. Single F2 progeny were
placed at L2/L3 stage onto pop-1 feeding plates. Homozygous haf-6 animals
gave rise to F3 progeny, and the presence of the marker phenotype was noted
for estimations of linkage or recombination frequency. The ne335 mutation
mapped to the left end of chromosome I. A series of overlapping yeast
artificial chromosomes (YACs) corresponding to this region were obtained
from the C. elegans Sequencing Consortium (Sanger Institute, Cambridge,
United Kingdom). YAC DNA was obtained by preparing total genomic DNA
from yeast. Purified DNA was injected into ne335 mutants and rescue of
RNAi defects was assayed using pop-1 and elt-2 food.
For complementation testing, crosses were performed using one hermaph-
rodite per mating on standard OP50 plates. The presence of 50% males in the
progeny indicated a successful cross. Complementarity was assessed in re-
ciprocal crosses: 1) haf-6(ne335) hermaphrodites were mated with smg-
2(e2008); him-5(e1417) males, and 2) smg-2(e2008) hermaphrodites were mated
with haf-6(ne335); him-5(e1417); ccIs8160 [rpL28::gfp] males. The green fluores-
cent protein (GFP)-expressing transgene (generously provided by Dr. A. Fire)
(Timmons et al., 2003) facilitated detection of cross-progeny. Cross-progeny
were transferred as L1/L2 larvae onto pop-1 feeding plates; unc-22 food
elicited similar results. Complementation between smg-2 and haf-6 was tested
at 20 and 25°C, with similar results.
Plasmids and Transgenic Strains
Transgene lines were established as complex arrays to better ensure expres-
sion in the germline (Kelly et al., 1997). DNA sequences were linearized before
injecting. A plasmid harboring a dominant mutation in the rol-6 gene was
used as transformation marker; bacteriophage lambda DNA or C. elegans
genomic DNA was used as carrier.
DNA Segments Used in Plasmid Cloning. 1) The haf-6 cDNA extends from the
initiator ATG, lacks a 5-untranslated region (UTR), includes its 3-UTR, and
was generated by reverse transcription (RT)-PCR using wild-type RNA as
template and primers 472 ATGTCAATTCTATCTAAACTATCCC and 473
CTTTAATATTTCTACTAAAATTTAAA. 2) A smg-2 cDNA, lacking in 5-
UTR sequences, harbors an initiator ATG and 3-UTR and was amplified by
RT-PCR using wild-type RNA as template and primers 488 ATGGACGAT-
TCGGACGACGAATATTCGAGAAGCCACGGGG and 489 AATTTTTCTA-
AAAATTTCGGATTTTCGAGAGAAAATCAAGC. 3) The ends of the haf-6/
smg-2 intergenic region are bounded by the 5-UTRs corresponding to each
gene. This fragment was obtained by PCR amplification using wild-type
DNA as template and primers 501 TTTACTAGTGATATCTAAAAACCAG-
GAAAAATCAATACAAATCAA and 502 TTTTTCTAGAGCTAGCTACTG-
GAAGAAAAGTGCGTTTTTGAGGGGT. 4) Five hundred and forty-nine base
pairs of let-858 promoter (including its 5-UTR) were used to drive ubiquitous
expression (Kelly et al., 1997). Primers 343 TTTTTGCATGCGTCGACGCTCT-
GAAAAACGAAAGTGGA and 344 TTTGGATCCCTTACTATAAAAAAGTTT-
GAATAC were used to amplify this segment from wild-type DNA. 5) The smg-2
frameshift (insertion) was generated by first assembling a plasmid with tripartite
sequences composed of the smg-2 and haf-6 cDNA sequences flanking the smg-
2/haf-6 intergenic region configured in the chromosomal context with cDNAs in
opposite orientation. The tripartite plasmid was then digested with AgeI, which
cuts once within the smg-2 cDNA (1923 base pairs downstream from ATG), and
AgeI ends were filled in with T4 DNA polymerase and ligated to regenerate a
circular plasmid with a four- base pair insertion in the smg-2 coding region. 6)
The smg-2 deletion was generated from the tripartite plasmid by digesting the
smg-2 cDNA region with Nde I and religating, resulting in the removal of base
pairs 391-2866 (with ATG at position 1). 7) 2385 base pairs of myo-3 promoter
sequence, including its 5-UTR were used to drive expression in muscle (Fire et
al., 1998). Primers 497 ttagcggatccgctagcAAGCTTGGGCTGCA GGTCGGC and
498 ttagcggatccgcggccgcTCTAGATGGATCTAGTGGTCGTGG were used to am-
plify the promoter. DNA sequencing confirmed each fragment was error-free.
Fragments were cloned into standard vectors and combined to produce the
plasmids described using standard cloning techniques. Transgene lines were
established as described above.
Transgene-mediated Rescue of RNAi. RNAi activity in transgenic animals was
assessed by placing animals as L2/L3 larvae on pop-1 or elt-2 food. Absence of
live progeny is indicative of an intact RNAi response.
Transgene-mediated Rescue of Nonsense-mediated Decay (NMD). Plasmids
were injected as described above into smg-2(r908), unc-54(r293) hosts, and
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phenotypes in the resulting transgenic strains were noted. unc-54(r293) carries
a premature stop codon that produces a paralyzed phenotype in wild type;
the phenotype is suppressed in animals defective for smg-2 (Hodgkin et al.,
1989). (unc-54 mRNA is not degraded in smg-2 mutants, allowing for expres-
sion of a near full-length UNC-54 protein.) Functional SMG-2 activity is
evidenced by a paralyzed phenotype.
HAF-6::GFP Reporters. Seven plasmids were designed for assays of protein
localization and mutant rescue. GFP sequences were derived from plasmids
pPD119.45, pPD118.37, pPD96.02, pPD119.16, and pPD102.33 (obtained from
FireLab Vector kit; Andrew Fire). Plasmids were coinjected with carrier DNA
and transformation marker sequences (dominant rol-6) into wild-type animals
and were established as extrachromosomal, complex arrays. GFP fluorescence
Figure 1. ne335 is an allele of haf-6. (A) haf-6 maps to the left arm of chromosome I. We scored 300–500 F2 progeny animals in each mapping
experiment. YAC Y48G8, which rescues the RNAi defect in haf-6(ne335) mutants, is indicated. The haf-6 gene is approximately 700 bp
upstream of smg-2 and is oppositely transcribed, an indication that the genes may have regulatory elements that are shared or that compete.
Both genes reside in Y48G8. (B) Revised intron/exon structure of haf-6. We found an additional 303 base pairs of coding region not predicted
in Wormbase (release WS146). The 35-base pair deletion in haf-6(ne335) is indicated by a filled triangle. The deleted region is lowercase. The
five horizontal lines at the bottom of diagram highlight the relative positions of the five predicted transmembrane helices. The thick lines
represent exons; thin lines indicate introns. (C) Predicted transmembrane topology of HAF-6 (Krogh et al., 2001); the ABC is C-terminal. The
set of five transmembrane helices constitutes a transmembrane domain (TM). (D) Rescue of RNAi defects in haf-6(ne335) mutants by Y48G8
but not from an unrelated YAC. RNAi defects were assessed on pop-1 feeding plates at 20°C. Bars represent the average of five experiments;
error bars represent SD. In total, seven overlapping YACs were tested; data from Y65B4 are included in the figure as a representative negative
control. Only Y48G8 provided rescue, demonstrating that specific sequences, as opposed to the presence of a transgene, provide rescue. (E)
Rescue of RNAi defects in haf-6 mutants. The pLT501 and pLT372 plasmids harbor a full-length haf-6 cDNA driven from haf-6 upstream/
promoter sequences (see Figure 2, construct 5). The HAF-6 sequence in pLT501 harbors a G562R amino acid substitution; plasmid pLT372
is wild type for HAF-6. Bars represent an average of two experiments; error bars denote the range. Gray bars represent different transgenic
lines derived independently from the same DNA injection mix.
P. Sundaram et al.
Molecular Biology of the Cell3680
patterns were monitored in live animals, and the subcellular patterns were
similar to those observed using our anti-HAF-6 polyclonal antibody. GFP
expression was also monitored using an anti-GFP monoclonal (Sigma-
Aldrich, St. Louis, MO) to detect expression in the germline.
Antibodies and Immunofluorescence Microscopy
A peptide corresponding to amino acids 69–82 (IDHLRTTEDQNASMC) was
cross-linked to keyhole limpet hemocyanin as hapten [coupled using 1-ethyl-
3-(3-dimethylaminopropyl)carbodiimide hydrochloride] and injected into
rabbits (Harlan Bioproducts for Science, Indianapolis, IN) (Supplemental
Figure 1). Immune serum was affinity purified using a column coupled with
HAF-6::glutathione S-transferase (GST) fusion protein derived from a pGEX-
4T-2 vector (GE Healthcare, Little Chalfont, Buckinghamshire, United King-
dom). The HAF-6::GST fusion harbored the first 100 amino acids of HAF-6.
The fusion protein was covalently coupled to CNBr-activated Sepharose 4B
(Sigma-Aldrich). Remaining antibodies that might cross-react to bacterial
proteins were adsorbed onto a second column coupled with bacterial proteins
derived from a similar purification protocol as HAF-6::GST. Tissue was
prepared for immunofluorescence using a number of different fixation and
permeabilization conditions and solutions, including methanol, formalde-
hyde, or paraformaldehyde fixatives. Animals were permeabilized by freeze-
cracking on glass slides using fixative solutions containing either methanol,
4% formaldehyde, or 4% paraformaldehyde in phosphate-buffered saline. Not
surprisingly, methanol fixation removed some signal from membranes, con-
firming the specificity of the antibody preparation; paraformaldehyde fixation
resulted in a more pronounced nuclear envelope staining; and formaldehyde
fixative or formaldehyde/paraformaldehyde mixes produced consistent
staining with patterns similar to reporter GFP patterns in live animals. We
also permeabilized animals en masse in Eppendorf tubes (Finney and Ru-
vkun, 1990) with variations on the protocol that included omission of meth-
anol and/or detergents. Additionally, animals were dissected in fixative
using syringe needles to achieve permeabilization. The anti-Complex IV
subunit I antibody was purchased from MitoSciences (Eugene, OR); anti-
calreticulin antibodies were a gift from Joohong Ahnn (Gwangju Institute of
Technology, Gwangju, Korea) (Park et al., 2001). Fluorescent images were
obtained using a Zeiss LSM510 Meta confocal microscope system (Carl
Zeiss Microimaging, Thornwood, NY). Goat anti-mouse and goat anti-
rabbit secondary antibodies were coupled to Alexa 488 or Alexa 594
(Invitrogen, Carlsbad, CA).
RESULTS
ne335 Is an Allele of haf-6
The ne335 allele was isolated based on its “method-of-deliv-
ery-dependent” RNAi defects (Tabara et al., 1999). ne335
mutants elicit RNAi when dsRNA is introduced by injection
(Fire et al., 1998), but they are RNAi defective when worms
are reared on “dsRNA food” (bacteria that express dsRNA
corresponding to a particular worm gene) (Timmons et al.,
2001). We mapped the ne335 mutation to the left end of
chromosome I using standard methodology and pop-1 or
unc-22 food to identify homozygotes and recombinants (Fig-
ure 1A). The single gene Y48G8AL.11 rescued the RNAi
defects in ne335 (Figure 1, A, B, D, and E). Y48G8AL.11 is
named haf-6 based on its homology to half-molecule ABC
transporters. Although full ABC transporter proteins have
two sets of transmembrane-spanning domains and two do-
mains with homology to ATP-binding cassettes, half-trans-
porters have only one of each domain (Figure 1C and Sup-
plemental Figure 1). The molecular lesion in the ne335 allele
is a 35-base pair deletion in exon 3 of the haf-6 gene (Figure
1B), and the mutated gene is predicted to produce a partial
protein with only the first two transmembrane-spanning
helices but no ATPase domain.
The Neighboring Gene, smg-2, Does Not Contribute to the
RNAi Defect in haf-6(ne335)
Although robust RNAi phenocopies are observed in re-
sponse to delivery of dsRNA, the effect is not permanent.
Faster recovery of RNAi has been observed in smg-2 mutants
injected with dsRNA in comparison with similarly injected
wild-type animals (Domeier et al., 2000). The smg-2 gene is
located 700 base pairs upstream of haf-6, and the genes are
oppositely transcribed (Figure 1A). Because the two genes
are juxtaposed and may have overlapping regulatory ele-
ments, we considered that smg-2 activity might be impaired
in ne335 mutants, contributing to the RNAi defects we ob-
serve. SMG-2 activity is required for some aspects of mRNA
surveillance, a mechanism that degrades defective mRNAs,
in particular those mRNAs harboring a premature stop
codon. smg-2 mutants act as allele-specific suppressors of
NMD (Hodgkin et al., 1989; Page et al., 1999; Anders et al.,
2003; Grimson et al., 2004), and we used this property in
functional assays for SMG-2 activity.
We took a transgenic approach to determine whether
smg-2 activity might be affected by the mutation in haf-6
(Figure 2A). cDNA sequences, and not genomic regions, for
haf-6 and smg-2 were used due to the presence of unclonable
inverted repeats in several introns of both genes; further-
more, no cosmids were subcloned from this region by the C.
elegans DNA Sequencing Consortium. The haf-6 cDNA alone
rescued the RNAi defects in haf-6(ne335) when driven ubiq-
uitously from a let-858 promoter (Figure 2A, construct 1).
The smg-2 cDNA alone did not rescue the RNAi defects in
haf-6(ne335) mutants, but it did rescue NMD defects in smg-2
mutants (Figure 2A, construct 3). A single construct harbor-
ing both cDNAs flanking the intergenic region was able to
rescue both the NMD defect in smg-2 and the RNAi defect in
haf-6(ne335) mutants, as expected (Figure 2A, construct 4).
Figure 2. smg-2 does not contribute to the RNAi defects in haf-
6(ne335). (A) DNA constructs injected into mutants were configured
as indicated. Transgenic lines for each plasmid were established in
both haf-6(ne335) and smg-2(r908), unc-54(r293) mutant back-
grounds. Each haf-6(ne335) transgenic strain was tested for RNAi
activity; each smg-2(r908), unc-54(r293) transgenic strain was tested
for NMD as described in Materials and Methods. haf-6 mutant animals
without transgenes did not display RNAi activity in these assays;
likewise, the nontransgenic smg-2, unc-54 mutant strain did not
display NMD. Rescue of RNAi defects in haf-6 mutants was depen-
dent upon proper expression of haf-6 sequences; rescue of NMD in
smg-2 mutants was dependent on intact SMG-2 activity. The design
of constructs 3–6 reflects the chromosomal, oppositely oriented,
arrangement of the genes. A smg-2 coding segment is required for
full haf-6 expression (compare 2 and 4 with 6 and 5). (B) No RNAi
defects are observed in smg-2 mutants using feeding assays, and the
haf-6 and smg-2 alleles do not complement. (Both pop-1 and unc-22
foods were used in these experiments.)
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Plasmids with this tripartite configuration of DNA segments
that harbored a smg-2 cDNA with a frameshift mutation
(Figure 2A, construct 5) or with a deletion (Figure 2A, con-
struct 5) were generated. These plasmids did not allow
rescue of NMD, as expected; furthermore, construct 5 did
rescue RNAi defects in haf-6(ne335). Extra copies of smg-2 in
the haf-6(ne335) mutant background did not improve the
RNAi defects in our transgene-based assays; thus, the ne335
mutation has no apparent effect on smg-2. By contrast, we
observed that part of the smg-2 coding region is required for
full haf-6 expression (Figure 2A, constructs 2 and 6 com-
pared with constructs 4 and 5), possibly acting as a tran-
scriptional enhancer.
Additional data support the conclusion that smg-2 activity
is not affected by the 35-base pair deletion in haf-6(ne335)
and that the RNAi defects we observe are solely due to
defects in haf-6: 1) The smg-2 sequence is wild type in haf-6
mutants, ruling out the possibility that mutations in two
genes coexist in this strain. 2) We easily obtained smg-2
cDNA by RT-PCR using RNA from haf-6 mutants as tem-
plate, suggesting the smg-2 gene is expressed (our unpub-
lished data). 3) The RNAi defects in haf-6 are complemented
by smg-2 mutants (Figure 2B). 4) When our feeding assays
(pop-1 and unc-22 foods) are used to test the RNAi capability
of smg-2(r908) and smg-2(e2008) mutants, we observed no
RNAi defects at any growth temperature (15, 20, or 25°C;
Figure 2B). The proximity of the genes, the presence of haf-6
regulatory elements in the smg-2 coding region, and the
potential for other forms of shared regulation raise the pos-
sibility that some smg-2 mutants, especially those with large
deletions, might also have disruptions in haf-6, complicating
analyses of RNAi defects in these strains.
An Intact ABC Domain Is Required for HAF-6 Activity in
RNAi
We verified our subcloned fragments by DNA sequencing
and found that the haf-6 cDNA in plasmid pLT501 (Figure
1E) had acquired a point mutation during PCR amplifica-
tion. [This mutation is not present in the genome of wild
type or haf-6(ne335).] The mutation is predicted to result in
Figure 3. haf-6 mutants display dose-dependent and tissue-specific RNAi defects. Injection (A), soaking (B), and feeding (C) methods were
used to deliver dsRNA. (A–C) pop-1(RNAi) phenocopies (sterility) were assessed by scoring the number of F1 progeny per treated animal for
a defined time frame. (A) Various dilutions (from 10 to 50 ng/l) of pop-1 dsRNA were injected into the body cavity of L3/L4 animals that
were subsequently cultured on standard plates at 20°C and also at 25°C (our unpublished data). No temperature-dependent differences in
RNAi activity were observed. Ten to 18 animals (average 12.2) were injected in each set. (B) Animals were soaked in 50 ng/l pop-1 dsRNA
as L1/L2 at 20°C, and each animal was recovered onto individual culture plates. Bars represent the number of progeny produced over a
defined time period from treated individuals. The horizontal lines above each set of bars represent the average number of progeny produced
for the particular strain: 3.3 progeny/adult in wild type; 44.6 for haf-6(ne335). Individual soaked mutants displayed a more variable
phenocopy penetrance than did wild type; however, average overall RNAi response in mutants was lower than wild type. The variation in
response is likely correlated to the amount of material ingested by individuals and hence to the dosage of dsRNA. (C) Animals were placed
onto pop-1 food as L1/L2 and monitored for sterility at 20°C over a defined time, identical conditions were used in each set of experiments.
(D) haf-6 mutants are RNAi defective in germline and intestine. The feeding protocol was used to deliver dsRNAs corresponding to the genes
indicated. Animals were placed at L1/L2 stage onto feeding plates. All feeding strains elicited an RNAi phenocopy in wild-type. Experiments
were performed at 15, 20, and 25°C, with similar results.
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an amino acid substitution of Arg for Gly at amino acid
position 562 (Supplemental Figure 1). Gly562 is strictly con-
served and resides only three amino acids upstream from
the signature conserved motif (LSGGQ) specific to ABC
transporters (Supplemental Figure 1), and G562 likely plays
an important role in nucleotide binding. The G562R muta-
tion rescued RNAi defects in haf-6(ne335); however, the rel-
ative ability of the R562G form to rescue RNAi was notably
reduced in comparison with the ability of intact haf-6 se-
quences to rescue (Figure 1E, plasmid 501 has the G562R
mutation and plasmid 372 is wild type). Our interpretation
of the results is that the G562R substitution produces a
HAF-6 protein with a weakened ability to bind and/or
hydrolyze nucleotides with the result that the RNAi activity
is also weakened. Thus the RNAi role for HAF-6 likely
requires substrate transport.
Phenotypic Analysis of haf-6(ne335)
haf-6 mutant animals are viable and fertile, yet display meth-
od-of-delivery–dependent RNAi defects. We used the full
spectrum of dsRNA delivery methods available in C. elegans
to better understand the nature of the RNAi defects in
haf-6(ne335). We report two main observations.
First, the RNAi defect in haf-6(ne335) mutants is dosage
sensitive with respect to the amount of dsRNA. An RNAi
response is observed when relatively high concentrations of
dsRNA are injected; lower concentrations are less effective in
eliciting an RNAi response in mutants (Figure 3A). Experi-
ments using soaking methods also reveal a concentration-
dependent RNAi response (Figure 2B)—treatment of mu-
tants with a relatively high concentration of dsRNA was
required for a robust RNAi phenocopy in the population.
With soaking, wide variations in penetrance of RNAi phe-
nocopies can be attributed to individual variations in the
amount ingested. Although soaking and injection can elicit
RNAi in mutants, feeding is most effective in revealing their
RNAi defects (Figure 2C).
Second, we observe RNAi defects in haf-6(ne335) for genes
that are expressed in germline and intestine but not other
tissues (Figure 3D). We initially considered that haf-6, a
method-of-delivery–dependent mutant, might be defective
in the dissemination of feeding-derived dsRNAs from the
intestine to other tissues. However, some systemic RNAi
responses are intact in haf-6 mutants, as evidenced by the
appearance of RNAi phenocopies 1) in somatic tissue when
dsRNA is introduced by feeding and 2) in treated animals
and their progeny from dsRNA introduced by soaking and
injection. Thus, an efficient RNAi response to dsRNA, in
particular to dsRNA delivered by bacterial feeding, is sen-
sitive to the relative levels of HAF-6 activity as well as to the
dosage of dsRNA.
Subcellular Localization of HAF-6
Most organisms harbor multiple ABC protein genes (Holland et
al., 2003)— 60 ABC transporter genes have been identified
in C. elegans (Sheps et al., 2004). Collectively, the different
ABC transporters localize to most membranes in the cell,
including the plasma membrane, endoplasmic reticulum,
and mitochondria. Determining the subcellular localization
of HAF-6 is key to understanding the role of HAF-6 in RNAi
and to the identification of transportable substrates that are
relevant to its RNAi function. HAF-6 is a half-transporter
member of the B subfamily, and an additional eight half-
transporter genes in subfamily B are encoded by the C.
Figure 4. GFP reporter plasmid configurations used to build transgenes. Plasmids were configured as indicated and injected into wild type
and haf-6 mutants. The number of independently established lines is indicated. GFP fusion proteins expressed in muscle from plasmid
pLT428 displayed weak fluorescence, and the ability of the transgenic animals to express GFP was lost over generational time. We observed
a clear ER localization pattern for GFP in the few muscle cells with fluorescence. Only plasmid pLT531 elicited stable GFP fluorescence. The
pLT531 plasmid was injected into haf-6(ne335) mutants to generate strain XX915. XX915 animals displayed GFP fluorescence in a pattern
similar to that observed in wild type, and the RNAi phenotypes were rescued.
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elegans genome (Sheps et al., 2004). The precise functions,
substrates, and subcellular localizations of half-transporters
in C. elegans have not been fully investigated. Mammalian
half-transporters from subgroup B function as heterodimers,
and possibly homodimers in the endoplasmic reticulum;
others localize to mitochondria or lysosomes (Monaco et al.,
1990; Spies et al., 1990; Allikmets et al., 1996; Csere et al., 1998;
Hogue et al., 1999; Yamaguchi et al., 1999; Mitsuhashi et al.,
2000; Zhang et al., 2000a,b). Because not all members of the
same subfamily are similarly localized, subfamily classifica-
tion does not allow predictions of subcellular localization.
Additionally, localization domains have been identified for a
relatively few transporter proteins, and the degree of evolu-
tionary conservation of such motifs has yet to be deter-
mined.
We first built plasmids to express HAF-6::GFP fusion pro-
teins in C. elegans (Figure 4). The different constructs pro-
duced three variations of GFP fusions: an N-terminal
GFP::HAF-6 protein, a C-terminal HAF-6:: GFP protein, and
an internal GFP sequence in-frame within the entire HAF-6
protein. Expression of GFP fusion proteins was driven from
haf-6/smg-2 promoter segments that provided rescue in pre-
vious experiments (Figure 2, construct 5), from a myo-3
promoter segment that drives expression in muscle, or from
a let-858 promoter that drives expression in all cells. Each
construct was injected into wild-type and haf-6 mutant ani-
mals as described in Materials and Methods, and transgenic
lines were established. GFP accumulation was observed in
only two plasmid configurations (Figure 4): 1) Muscle cells
in transgenic lines harboring plasmid pLT428 expressed
GFP; however, the expression was weak and was observed
only in a few anterior muscle cells in each animal. Addition-
ally, not all transgenic animals (with the Roller transforma-
tion marker phenotype) displayed GFP fluorescence, and
GFP expression was not meiotically stable—no GFP was
observed in these lines past the F3 generation. However, in
GFP-expressing muscle cells, we observed intracellular flu-
Figure 5. HAF-6 is expressed in intestine and germline and local-
izes to intracellular, reticular membranes. Endogenous GFP fluores-
cence from a rescuing HAF-6::GFP fusion protein (Figure 4, plasmid
pLT531) and immunolocalizations using anti-HAF-6 and control
antibodies were used to investigate subcellular distribution pat-
terns. (A) HAF-6::GFP fluorescence patterns in live animals (left and
center) are similar to the patterns observed in fixed animals deco-
rated with an anti-HAF-6 antibody (right). White arrows, intestinal
nuclei; red arrows, autofluorescent granules. (B) The HAF-6::GFP
protein (left) is localized to the same compartment as calreticulin
(CRT-1), a primarily ER resident with a C-terminal KDEL sequence.
Similar results were obtained in cohybridization experiments using
the anti-HAF-6 antibody with anti-CRT-1. HAF-6 is a transmem-
brane protein, and 100% spectral overlap with CRT-1 is not antici-
pated; nonetheless, co-compartmentalizaion is observed. (C) Cohy-
bridization experiments were performed in transgenic animals
expressing both endogenous HAF-6 and a HAF-6::GFP fusion pro-
tein. The signals from anti-GFP and anti-HAF-6 overlapped, indi-
cating that the fusion protein is expressed in all the compartments
where the endogenous protein is located. (D) A control experiment
demonstrating that subcellular compartments can be distinguished
in germline tissue fixed with formaldehyde. Mouse anti-Complex IV
subunit I antibodies recognize mitochondrial proteins. Rabbit anti-
CRT-1 antibodies recognize proteins localized mostly to the endo-
plasmic reticulum. (E) A control experiment demonstrating that
distinct compartmentalization patterns are also observed using
methanol as fixative. (F) HAF-6 localization patterns do not resem-
ble mitochondrial patterns in germline. HAF-6 patterns are reticular
in germline. (G) HAF-6 protein is perinuclear in germline tissue;
perinuclear staining is less prevalent in intestinal cells. Both tissues
shown are from the same animal. Confocal images were captured
using a Zeiss LSM 510 META. Bars, 5 m on all panels except A (10
m) and F and G (2 m).
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orescence that was clearly reticular and not mitochondrial
(our unpublished data). 2) The second construct, pLT531,
displayed a more robust GFP fluorescence (Figure 5A).
HAF-6::GFP expression in this plasmid was regulated by a
let-858 promoter that drove ubiquitous expression. Fluores-
cence from the same HAF-6::GFP construct did not accumu-
late to visible levels when driven from an endogenous haf-
6/smg-2 promoter (pLT438 and pLT510). Because the let-858
promoter drives ubiquitous expression, we anticipated that
GFP would be observed in all cells of transgenic lines har-
boring pLT531. However, we observed GFP expression
mostly in the germline and intestine, those tissues that dis-
play RNAi defects (Figure 3D). (Germline expression of GFP
was observed using anti-GFP antibodies and immunofluo-
rescent microscopy.) The more limited tissue expression pat-
tern may reflect the absence of a heterodimeric binding
partner in the nonfluorescent tissues.
The RNAi defect in mutant animals was rescued by the
HAF-6::GFP fusion protein; however, this does not preclude
the possibility that some GFP fluorescence might originate
from misfolded or nonfunctional proteins trapped in the
endoplasmic reticulum. We therefore validated our GFP
fluorescence observations using immunolocalization tech-
niques and an antibody specific to HAF-6 protein.
ABC transporter proteins have a high degree of amino
acid similarity. The N-terminal region of HAF-6 has little
similarity to other ABC proteins in C. elegans, so we gener-
ated an anti-peptide polyclonal antibody targeting this re-
gion (Supplemental Figure 1). The deletion in the haf-6(n335)
is not predicted to affect the region that encodes the epitope.
Indeed, we do observe antibody staining in the mutant,
indicating that HAF-6 protein, probably a truncated version,
is expressed. [We were not able to isolate a full-length cDNA
from haf-6(ne335) RNA by RT-PCR and anticipated that the
RNA might be more susceptible to degradation.] The spec-
ificity of the antibody is demonstrated by the observation of
similar staining patterns in experiments using anti-HAF-6
antibody versus experiments using GFP reporters from a
construct that provides rescue of the RNAi defects. Further-
more, we have developed antibodies against other HAF
proteins, and we observe patterns that are distinct from
HAF-6 (our unpublished data).
Immunofluorescence staining revealed that HAF-6 was
predominantly expressed in intestinal and germline tissue
(Figure 5), a pattern that mirrors the RNAi defects observed
in mutants (Figure 3D). Thus haf-6 RNAi defects are appar-
ently limited to the tissues where HAF-6 is expressed. In
double-labeling experiments, the anti-HAF-6 antibody did
not decorate the same cellular compartment as a mitochon-
drial antibody (anti-Complex IV). We did observe co-com-
partmentalization using anti-HAF-6 and anti-Calreticulin
antibodies, indicating that HAF-6 likely resides in the
endoplasmic reticulum and not in mitochondria, as was
expected from comparisons of sequence similarity to human
half-transporters. Interestingly, HAF-6 localization extended
to perinuclear regions in germline tissue, which is consistent
with an endoplasmic reticulum (ER) localization (Figure
5G). However, localization of HAF-6 to the nuclear periph-
ery was not prominent in intestinal tissue. Furthermore, the
subcellular patterns observed in experiments using anti-
HAF-6 antibody were similar to the patterns of GFP expres-
sion observed in transgenic animals expressing the
HAF-6::GFP fusion protein (Figure 5A).
Additional ABC Transporters Facilitate RNAi
The C. elegans genome encodes 61 genes with sequence
homology to ABC transporters (Sheps et al., 2004). Strains
that harbor defects in 43 of these genes were tested for RNAi
activity using pop-1 and unc-22 food (see Materials and Meth-
ods). We observed strong defects in eight additional strains
(Table 1)—this set includes full-transporter as well as half-
transporter molecules from a wide distribution of subfami-
lies. Some transporter genes have overlapping patterns of
expression in somatic tissue, whereas others have nonover-
lapping and more restricted patterns of expression (Zhao et
al., 2004). Given the high degree of sequence homology
between ABC transporters, the diversity of expression pat-
terns, and the variety of configurations of transmembrane
and ABC motifs in this set of genes, we cannot yet ascribe an
RNAi function to a common sequence-related feature. Be-
cause all the strains in this set are RNAi-defective for germ-
line targets, we predict a germline function for these trans-
porters. Most surprising is the observation that nine ABC
proteins are nonredundantly required for efficient RNAi;
however, because the RNAi defect in any single mutants is
rather weak, their effects may be additive.
Table 1. Additional ABC transporters are required for efficient RNAi in C. elegans
ABC subfamily Strain
RNAi activity on
Predicted topologypop-1 food unc-22 food
A abt-1(tm0703) Defective Wild type (6TM-ABC)2
B pgp-4(gk16) Defective Wild type (6TM-ABC)2
B pgp-11(tm33) Defective Wild type (6TM-ABC)2
B haf-2(gk13) Defective Defective 8TM-ABC
B haf-6(ne335) Defective Defective, heat sensitive 5TM-NFB
C mrp-1(pk89) Defective, cold sensitive Wild type (12/6TM-ABC)2
D pmp-1(ok773) Defective Wild type 4TM-ABC
G C16C10.12(ok962) Defective Wild type ABC-4TM
G C05D10.3(tm688) Defective Wild type ABC-4TM
Deletion strains of ABC transporters were reared on pop-1 and unc-22 feeding plates at 15, 20, 25, and 26°C. pop-1 RNAi phenocopies (sterility)
and unc-22 phenocopies (twitching) were assessed and compared with those of wild type. Notations on the predicted topology and ABC
classification systems were derived from Sheps et al. (2004). Strains testing negative in these assays harbored mutations in the following genes
(see Materials and Materials): abt-2; abt-4; C56E6.1; ced-7; cft-1; F02E11.1; F19B6.4; haf-1; haf-3; haf-4; haf-5; haf-7; haf-8; haf-9; mrp-3; mrp-4; mrp-6;
mrp-8; pgp-1; pgp-2; pgp-3; pgp-5; pgp-6; pgp-7; pgp-10; pgp-12; pgp-13; pmp-3; pmp-4; pmp-15; T26A5.1; T27E9.7; TAG-167; Y42g9a.6; Y49e10.9.
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DISCUSSION
The haf-6 gene encodes a half-molecule transporter with
homology to members of the B subclass of ABC transporters.
Most organisms harbor many different ABC transporter
genes, and the C. elegans genome has at least 60 (Sheps et al.,
2004). Transporters are classified into subgroups based on
the overall level of homology and the numbers and arrange-
ment of the two conserved domains: the transmembrane
domain, made up of multiple transmembrane-spanning he-
lices, and the ABCs. ABC transporters can be found in
virtually all membranes of the cell, including those of sub-
cellular organelles, although some ABC proteins lack trans-
membrane-spanning domains. The small molecule sub-
strates transported by the collective ABC transporters
include lipids, peptides, ions, nucleotides, carbohydrates,
and drugs. Substrates can be transported into or out of cells
or between intracellular compartments, and substrate trans-
port is involved in various essential and nonessential cellu-
lar activities.
Generally, the amino acid sequence of an ABC transporter
allows few conclusions to be drawn regarding the substrates
that might be transported. We first anticipated that the ho-
mology between HAF-6 and the better-studied human half-
transporter molecules would provide clues to function, or
perhaps subcellular localization. HAF-6 has the most overall
sequence similarity to human transporters that localize to
mitochondria. However, HAF-6 seems to localize to reticular
membranes rather than mitochondrial membranes in our
observations of live animals expressing GFP and of anti-
body-stained fixed tissue. Thus, the overall amount of ho-
mology between transporters from different species does not
allow predictions regarding subcellular localization.
We observed RNAi defects in eight additional ABC trans-
porter-defective strains. Transporters are often expressed in
a tissue-specific manner in multicellular organisms, and ex-
pression patterns for most of the nine transporters in C.
elegans have been reported (Zhao et al., 2004). pgp-4 and
pgp-11 expression was observed in the excretory cell; pgp-11
is also expressed in intestinal tissue, as is mrp-1 and pmp-1;
additional mrp-1 expression was observed in the pharynx
and vulva, and C05D10.3 gene expression was observed in
embryos and the gut of males (Zhao et al., 2004). The expres-
sion patterns were determined using transgenes configured
to drive expression of GFP in live animals from promoter
(upstream) sequences of an ABC transporter gene. However,
it is generally the case that transgenes are silenced in the
germline and in young embryos (Kelly et al., 1997), so this
method is not a reliable indicator of gene expression in these
tissues. The RNAi defects we observed using pop-1 food
(Table 1) indicate a role in the germline for these genes.
Of the nine transporters that facilitate RNAi, haf-2 is the
only gene expressed in muscle (Zhao et al., 2004), and haf-
2(gk13) is the only mutant we tested with a strong muscle-
specific RNAi defect. Because the remaining eight mutant
strains did not display unc-22(RNAi) phenocopies in re-
sponse to ingestion of unc-22 food, the RNAi defects are
likely only observed in tissues where the ABC transporter in
question is normally expressed. None of the mutants is
likely to be strongly defective in the dissemination of silenc-
ing signals derived from ingestion of bacterial food, because
RNAi is active in some somatic tissues (muscle). However, a
fully systemic RNAi phenocopy in response to ingested
dsRNAs may depend upon the proper function and expres-
sion of multiple ABC transporters in multiple tissues. We
anticipate that tissue-specific RNAi defects may be observed
in additional ABC transporter mutants. We are currently
testing the remaining mutants using bacterial feeding strains
to target genes with expression patterns that overlap with
that of the ABC transporter in question.
Some ABC transporters export heavy metals, drugs, and
other toxins from cells, thereby providing protection from
harsh environments. A developmental program that results
in arrested dauer larvae, which are better adapted for sur-
vival in harsh conditions, is initiated when C. elegans en-
counters environmental stress. The ABC transporter mrp-1
allows animals to survive in environments laden with heavy
metals (Broeks et al., 1996) and has been demonstrated to
function in preventing dauer formation (Yabe et al., 2005).
Here, we report that mrp-1 mutants harbor RNAi defects
(Table 1). Thus, an unappreciated role for ABC proteins
during stress may be to influence RNAi mechanisms and
thereby affect developmental reprogramming.
ABC transporters are required for various physiological
activities, including protective or barrier mechanisms that
export drugs or toxins from cells (Broeks et al., 1996; Bauer et
al., 1999; Begley, 2004; Fromm, 2004) and mechanisms that
protect against viral infection (Trowsdale et al., 1990; Abele
and Tampe, 2004). A variety of human pleiotropic disorders
are linked to mutations in ABC transporters (Dean, 2005),
and transporters are up-regulated in some drug-resistant
cancers (Gottesman and Ambudkar, 2001; Gottesman and
Ling, 2006). Because alterations in ABC transporter function
contribute to a number of pathologies, understanding how
ABC transporters influence endogenous RNAi mechanisms
will prove relevant to disease etiology as well as environ-
mental adaptation. Furthermore, an ability to influence
RNAi may help explain the patterns of evolutionary conser-
vation of this diverse group of genes. We propose several
models to reason how ABC protein function might influence
RNAi: 1) ABC transporters may provide an appropriate
intracellular environment for proper RNAi biochemistry, 2)
ABC proteins may actively signal RNAi mechanisms
through the transport of specific substrates; or 3) ABC pro-
tein activity may redirect the activity of associated proteins
toward an RNAi function.
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